Edition:
United Kingdom

Checkpoint Therapeutics Inc (CKPT.OQ)

CKPT.OQ on NASDAQ Stock Exchange Capital Market

5.06USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$5.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,362
52-wk High
$10.50
52-wk Low
$3.35

Chart for

About

Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology... (more)

Overall

Beta: --
Market Cap(Mil.): $176.31
Shares Outstanding(Mil.): 25.37
Dividend: --
Yield (%): --

Financials

BRIEF-Checkpoint Therapeutics files for mixed shelf offering of up to $100 mln - SEC filing‍​

* Checkpoint Therapeutics Inc - files for mixed shelf offering of up to $100 million - SEC filing‍​ Source text: (http://bit.ly/2zKSDGZ) Further company coverage:

09 Nov 2017

BRIEF-Checkpoint Therapeutics receives orphan drug designation for CK-101

* Checkpoint Therapeutics receives orphan drug designation for ck-101 for the treatment of egfr mutation-positive non-small cell lung cancer

11 Sep 2017

Earnings vs. Estimates